Strain identifier
BacDive ID: 8162
Type strain:
Species: Moraxella catarrhalis
Strain Designation: 1908
Strain history: <- Heinrich Mack Nachf. <- ATCC <- D.R. Nash <- C. Reading; 1908 <- G. Ninane
NCBI tax ID(s): 857580 (strain), 480 (species)
General
@ref: 4573
BacDive-ID: 8162
DSM-Number: 11994
keywords: Bacteria, mesophilic, human pathogen
description: Moraxella catarrhalis 1908 is a mesophilic human pathogen that was isolated from transtracheal aspirate from coal miner with chronic bronchitis.
NCBI tax id
NCBI tax id | Matching level |
---|---|
857580 | strain |
480 | species |
strain history
- @ref: 4573
- history: <- Heinrich Mack Nachf. <- ATCC <- D.R. Nash <- C. Reading; 1908 <- G. Ninane
doi: 10.13145/bacdive8162.20230509.8.1
Name and taxonomic classification
LPSN
- @ref: 20215
- description: domain/bacteria
- keyword: phylum/pseudomonadota
- domain: Bacteria
- phylum: Pseudomonadota
- class: Gammaproteobacteria
- order: Pseudomonadales
- family: Moraxellaceae
- genus: Moraxella
- species: Moraxella catarrhalis
- full scientific name: Moraxella catarrhalis (Frosch and Kolle 1896) Henriksen and Bøvre 1968 (Approved Lists 1980)
synonyms
@ref synonym 20215 Branhamella catarrhalis 20215 Mikrokokkus catarrhalis
@ref: 4573
domain: Bacteria
phylum: Proteobacteria
class: Gammaproteobacteria
order: Pseudomonadales
family: Moraxellaceae
genus: Moraxella
species: Moraxella catarrhalis
full scientific name: Moraxella catarrhalis (Frosch and Kolle 1896) Henriksen and Bøvre 1968
strain designation: 1908
type strain: no
Morphology
colony morphology
- @ref: 4573
- type of hemolysis: gamma
- incubation period: 2-3 days
Culture and growth conditions
culture medium
@ref | name | growth | link | composition |
---|---|---|---|---|
4573 | COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) | yes | https://mediadive.dsmz.de/medium/693 | Name: COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) Composition: Defibrinated sheep blood 50.0 g/l Columbia agar base |
4573 | CASO AGAR (MERCK 105458) (DSMZ Medium 220) | yes | https://mediadive.dsmz.de/medium/220 | Name: CASO AGAR (Merck 105458) (DSMZ Medium 220) Composition: Agar 15.0 g/l Casein peptone 15.0 g/l NaCl 5.0 g/l Soy peptone 5.0 g/l Distilled water |
culture temp
- @ref: 4573
- growth: positive
- type: growth
- temperature: 37
- range: mesophilic
Physiology and metabolism
compound production
- @ref: 4573
- compound: ß lactamase
metabolite utilization
@ref | Chebi-ID | metabolite | utilization activity | kind of utilization tested |
---|---|---|---|---|
68369 | 25115 | malate | - | assimilation |
68369 | 17128 | adipate | - | assimilation |
68369 | 27689 | decanoate | - | assimilation |
68369 | 24265 | gluconate | - | assimilation |
68369 | 17306 | maltose | - | assimilation |
68369 | 59640 | N-acetylglucosamine | - | assimilation |
68369 | 16899 | D-mannitol | - | assimilation |
68369 | 16024 | D-mannose | - | assimilation |
68369 | 30849 | L-arabinose | - | assimilation |
68369 | 17634 | D-glucose | - | assimilation |
68369 | 5291 | gelatin | - | hydrolysis |
68369 | 4853 | esculin | - | hydrolysis |
68369 | 16199 | urea | - | hydrolysis |
68369 | 29016 | arginine | - | hydrolysis |
68369 | 17634 | D-glucose | - | fermentation |
68369 | 27897 | tryptophan | - | energy source |
68369 | 17632 | nitrate | + | reduction |
68377 | 17634 | D-glucose | - | builds acid from |
68377 | 15824 | D-fructose | - | builds acid from |
68377 | 17306 | maltose | - | builds acid from |
68377 | 17992 | sucrose | - | builds acid from |
68377 | 18257 | ornithine | - | degradation |
68377 | 27897 | tryptophan | - | energy source |
metabolite production
@ref | Chebi-ID | metabolite | production |
---|---|---|---|
68377 | 35581 | indole | no |
68369 | 35581 | indole | no |
metabolite tests
@ref | Chebi-ID | metabolite | indole test |
---|---|---|---|
68377 | 35581 | indole | - |
68369 | 35581 | indole | - |
enzymes
@ref | value | activity | ec |
---|---|---|---|
4573 | catalase | + | 1.11.1.6 |
4573 | cytochrome-c oxidase | + | 1.9.3.1 |
68377 | tryptophan deaminase | - | 4.1.99.1 |
68377 | gamma-glutamyltransferase | - | 2.3.2.2 |
68377 | proline-arylamidase | - | 3.4.11.5 |
68377 | beta-galactosidase | - | 3.2.1.23 |
68377 | ornithine decarboxylase | - | 4.1.1.17 |
68369 | cytochrome oxidase | + | 1.9.3.1 |
68369 | gelatinase | - | |
68369 | beta-glucosidase | - | 3.2.1.21 |
68369 | urease | - | 3.5.1.5 |
68369 | arginine dihydrolase | - | 3.5.3.6 |
API 20NE
@ref | NO3 | TRP | GLU_ Ferm | ADH Arg | URE | ESC | GEL | PNPG | GLU_ Assim | ARA | MNE | MAN | NAG | MAL | GNT | CAP | ADI | MLT | CIT | PAC | OX |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4573 | + | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | + |
API NH
@ref | PEN | GLU | FRU | MAL | SAC | ODC | URE | LIP | PAL | beta GAL | ProA | GGT | IND |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4573 | - | - | - | - | - | - | + | - | - | - | - | - | - |
4573 | + | - | - | - | - | - | - | + | + | - | - | - | - |
4573 | - | - | - | - | - | - | - | + | - | - | - | - | - |
Isolation, sampling and environmental information
isolation
- @ref: 4573
- sample type: transtracheal aspirate from coal miner with chronic bronchitis
- country: Belgium
- origin.country: BEL
- continent: Europe
isolation source categories
Cat1 | Cat2 | Cat3 |
---|---|---|
#Infection | #Inflammation | |
#Host Body-Site | #Oral cavity and airways | #Trachea |
#Host Body Product | #Fluids | #Aspirate |
Safety information
risk assessment
- @ref: 4573
- pathogenicity human: yes
- pathogenicity animal: yes
- biosafety level: 2
- biosafety level comment: Risk group (German classification)
External links
@ref: 4573
culture collection no.: DSM 11994, ATCC 43617
straininfo link
- @ref: 77566
- straininfo: 41942
literature
topic | Pubmed-ID | title | authors | journal | DOI | year | mesh | topic2 |
---|---|---|---|---|---|---|---|---|
Metabolism | 17620351 | Metabolic analysis of Moraxella catarrhalis and the effect of selected in vitro growth conditions on global gene expression. | Wang W, Reitzer L, Rasko DA, Pearson MM, Blick RJ, Laurence C, Hansen EJ | Infect Immun | 10.1128/IAI.00073-07 | 2007 | Biofilms/growth & development, Energy Metabolism/genetics, Gene Expression Regulation, Bacterial/*physiology, Genes, Bacterial, Iron/metabolism, Metabolic Networks and Pathways/*genetics, Moraxella catarrhalis/*genetics/*metabolism, *Oligonucleotide Array Sequence Analysis, RNA, Bacterial/analysis/genetics/isolation & purification, Reverse Transcriptase Polymerase Chain Reaction | Transcriptome |
Metabolism | 18362134 | Moraxella catarrhalis expresses an unusual Hfq protein. | Attia AS, Sedillo JL, Wang W, Liu W, Brautigam CA, Winkler W, Hansen EJ | Infect Immun | 10.1128/IAI.01652-07 | 2008 | Amino Acid Sequence, Biofilms, Escherichia coli, Gene Expression Regulation, Bacterial/physiology, Genetic Complementation Test, Host Factor 1 Protein/chemistry/genetics/*metabolism, Molecular Sequence Data, Moraxella catarrhalis/genetics/growth & development/*metabolism, Mutation, Protein Binding, RNA/metabolism | Genetics |
Genetics | 20453089 | Genome analysis of Moraxella catarrhalis strain BBH18, [corrected] a human respiratory tract pathogen. | de Vries SP, van Hijum SA, Schueler W, Riesbeck K, Hays JP, Hermans PW, Bootsma HJ | J Bacteriol | 10.1128/JB.00121-10 | 2010 | Bacterial Proteins, Chromosomes, Bacterial, Energy Metabolism/physiology, *Gene Expression Profiling, Gene Expression Regulation, Bacterial/*physiology, Genes, Bacterial, *Genome, Bacterial, Humans, Iron/metabolism, Molecular Sequence Data, Moraxella catarrhalis/*genetics, Oxidative Stress, Protein Transport, Virulence Factors/genetics/metabolism | Metabolism |
Pathogenicity | 24192397 | Activity of the antiseptic polyhexanide against gram-negative bacteria. | Fabry WH, Kock HJ, Vahlensieck W | Microb Drug Resist | 10.1089/mdr.2013.0113 | 2013 | Anti-Bacterial Agents/pharmacology, Anti-Infective Agents, Local/*pharmacology, Biguanides/*pharmacology, Ciprofloxacin/pharmacology, Drug Combinations, Escherichia coli/*drug effects/growth & development, Gentamicins/pharmacology, Haemophilus influenzae/*drug effects/growth & development, Klebsiella pneumoniae/*drug effects/growth & development, Microbial Sensitivity Tests, Microbial Viability/drug effects, Moraxella catarrhalis/*drug effects/growth & development, Pseudomonas aeruginosa/*drug effects/growth & development, beta-Lactams/pharmacology | |
Pathogenicity | 28845768 | Investigation of Antimicrobial, Antioxidant, and Xanthine Oxidase--Inhibitory Activities of Phellinus (Agaricomycetes) Mushroom Species Native to Central Europe. | Kovacs B, Zomborszki ZP, Orban-Gyapai O, Csupor-Loffler B, Liktor-Busa E, Lazar A, Papp V, Urban E, Hohmann J, Vanyolos A | Int J Med Mushrooms | 10.1615/IntJMedMushrooms.v19.i5.10 | 2017 | Agaricales/*chemistry, Anti-Infective Agents/*pharmacology, Antioxidants/*pharmacology, Bacillus subtilis/drug effects, Basidiomycota/*chemistry, Europe, Methicillin-Resistant Staphylococcus aureus/drug effects, Moraxella catarrhalis/drug effects, Xanthine Oxidase/*antagonists & inhibitors |
Reference
@id | authors | catalogue | doi/url | title |
---|---|---|---|---|
4573 | Curators of the DSMZ | Leibniz Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH (DSM 11994) | https://www.dsmz.de/collection/catalogue/details/culture/DSM-11994 | |
20215 | Parte, A.C., Sardà Carbasse, J., Meier-Kolthoff, J.P., Reimer, L.C. and Göker, M. | 10.1099/ijsem.0.004332 | List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ | |
68369 | Automatically annotated from API 20NE | |||
68377 | Automatically annotated from API NH | |||
77566 | Reimer, L.C., Lissin, A.,Schober, I., Witte,J.F., Podstawka, A., Lüken, H., Bunk, B.,Overmann, J. | 10.60712/SI-ID41942.1 | StrainInfo: A central database for resolving microbial strain identifiers |